Abstract:Objectives: Non-invasive prenatal testing (NIPT) has been widely used in recent years. According to clinical experience from all hospitals providing prenatal screening services in Beijing, we explored the feasibility of using NIPT for the analysis of common foetal aneuploidies among pregnancies. Methods: In total, 68,763 maternal blood samples were collected from January 2020 to December 2020 at the Beijing prenatal diagnosis agency. Cases with positive screening results by NIPT detection were validated using prenatal diagnosis. Results: In total, 920 cases had a high-risk NIPT result, and 755 cases were shown to be truly positive by a chromosome karyotyping analysis; the prenatal diagnosis rate was 82.07% (755/920). Of the920 cases, there were 164 cases of T21, 70 cases of T18, 38 cases of T13, 360 cases of SCAs and 288 cases of other chromosomal abnormalities. The positive rates of T21, T18, T13, and SCAs were 0.24% (164/68,763), 0.10% (70/68,763), 0.06% (38/68,763) and 0.52% (360/68,763), respectively. The sensitivity and specificity were 98.17% and 99.92% for T21, 96.15% and 99.93% for T18, and 100% and 99.95% for T13, respectively. The PPVs of T21,T18,T13 and SCAs were65.24% (107/164), 35.71% (25/70), 18.42% (7/38) and 31.39% (113/360), respectively. For all indications, there were more higher T21/18/13 in the high-risk group than in the low-risk group (comprising only cases of voluntary request), with a positive rate of 0.46% vs. 0.27% ( p < 0.001), sensitivity of 99.16% vs. 91.30% ( p = 0.02) and PPV of 56.73%vs.32.81% ( p = 0.001), but there was no significant difference in specificity between the groups ( p = 0.71). The detection indication with the highest PPV (100%) by NIPT was ultrasound structural abnormalities and ultrasound soft marker abnormalities for T21 and ultrasound structural abnormalities and NT thickening for T18 and T13. The PPVs of different clinical indications of T21 ( p = 0.002), T13 ( p = 0.04) and SACs ( p = 0.02) were statistically significant. Conclusion: The high specificity, efficiency and safety (non-invasiveness) of NIPT can effectively improve the detection rate of common chromosomal aneuploidy, thereby reducing the occurrence of birth defects. We should encourage pregnant women with NIPT-high-risk results to undergo a prenatal diagnosis to determine whether the foetus has chromosomal abnormalities. More importantly, the screening efficiency of NIPT in the low-risk group was significantly lower than that in the high-risk group. Therefore, the use of NIPT in low-risk groups should be fully promoted, and socioeconomic benefits should be considered.

Noninvasive prenatal diagnosis of trisomy 21 using analysis of short tandem repeats

Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience.

Noninvasive Prenatal Testing of Trisomies 21 and 18 by Massively Parallel Sequencing of Maternal Plasma DNA in Twin Pregnancies.

Noninvasive Prenatal Screening of Fetal Aneuploidy without Massively Parallel Sequencing

Study on rapid genetic diagnosis of trisomy 21

Non-invasive Prenatal Diagnosis of Trisomy 21 by Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification

A Novel Diagnostic Strategy for Trisomy 21 Using Short Tandem Repeats.

The Application of NIPT Using Combinatorial Probe-Anchor Synthesis to Identify Sex Chromosomal Aneuploidies (scas) in a Cohort of 570 Pregnancies

Prenatal Diagnosis of Down Syndrome Using Cell-Free Fetal DNA in Amniotic Fluid by Quantitative Fluorescent Polymersase Chain Reaction.

Practical Application of Fluorescent Quantitative PCR on Trisomy 21 in Chinese Han Population

Detection of trisomies 13, 18 and 21 using non-invasive prenatal testing

Non-invasive Prenatal Testing for Detection of Trisomy 13, 18, 21 and Sex Chromosome Aneuploidies in 8594 Cases

Prenatal Diagnosis Of Trisomy 21 By Quantitatively Pyrosequencing Heterozygotes Using Amniotic Fluid As Starting Material Of Pcr

Performance of Non-Invasive Prenatal Testing for Trisomies 21 and 18 in Twin Pregnancies.

[Diagnosis of Down's syndrome using short tandem repeat loci D21S11, D21S1440 and Penta D].

Primary Study on Prenatal Molecular Diagnosis of Down Syndrome

Evaluation of prenatal screening for fetal chromosomal aneuploidies by non-invasive fetal cell-free DNA test

Non-invasive Prenatal Detection of Trisomy 21 by Quantifying Segmental Duplication in Maternal Plasma with Digital PCR

Development and validation of a novel 26-plex system for prenatal diagnosis with forensic markers

Rapid Detection of Chromosomal Aneuploidies by Multiplex Ligation-Dependent Probe Amplification

Non-invasive prenatal testing for the detection of trisomy 13, 18, and 21 and sex chromosome aneuploidies in 68,763 cases